SCHEMBL3052151

SCHEMBL3052151

COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)O

nearest known ligand 0.75

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.75
▸ LMNA P02545 1/20 0.75
▸ CYP3A4 P08684 1/20 0.75
▸ TDP1 Q9NUW8 1/20 0.75
▸ RXRA P19793 10/20 0.35
▸ RXRG P48443 9/20 0.34
▸ RXRB P28702 8/20 0.34
▸ RARA P10276 1/20 0.33
▸ RARB P10826 1/20 0.33
▸ RARG P13631 1/20 0.33
▸ KDM1A O60341 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27858356 1.00 ALDH1A1 (0.75) ALDH1A1LMNACYP3A4TDP1RXRA
SCHEMBL7206440 1.00 ALDH1A1 (0.75) ALDH1A1LMNACYP3A4TDP1RXRA
SCHEMBL6114467 1.00 ALDH1A1 (0.75) ALDH1A1LMNACYP3A4TDP1RXRA
SCHEMBL3052148 1.00 ALDH1A1 (0.75) ALDH1A1LMNACYP3A4TDP1RXRA
SCHEMBL11500290 1.00 ALDH1A1 (0.75) ALDH1A1LMNACYP3A4TDP1RXRA
SCHEMBL6448320 1.00 ALDH1A1 (0.75) ALDH1A1LMNACYP3A4TDP1RXRA
Acetamide SCHEMBL28686196 0.96 ALDH1A1 (0.70) ALDH1A1LMNACYP3A4TDP1RXRA
Acetamide SCHEMBL28932784 0.96 ALDH1A1 (0.70) ALDH1A1LMNACYP3A4TDP1RXRA
SCHEMBL11862944 0.93 ALDH1A1 (0.65) ALDH1A1LMNACYP3A4TDP1RXRA
SCHEMBL11862939 0.93 ALDH1A1 (0.65) ALDH1A1LMNACYP3A4TDP1RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0923292-B1 IMPROVED METHOD FOR SYSTEMIC ADMINISTRATION OF 2,4-DIENOIC ACID-TYPE INSECTICIDES TO TERRESTRIAL MAMMALS NOVARTIS AG (CH) 2003-07-02 — — EP claimed
JP-2002522389-A — — 2002-07-23 — — JP claimed
JP-2001524960-A — — 2001-12-04 — — JP claimed
US-20010021378-A1 Pesticide SYNGENTA CROP PROTECTION, INC. 2001-09-13 — — US claimed
US-6277867-B1 SYNERGISTIC MIXTURES CHINOIN GYOGYSZER ES VEGYESZETI (HU) 2001-08-21 — — US claimed
US-20010005511-A1 Insect control by insect growth regulators broadcast by volatilization WELLMARK INTERNATIONAL 2001-06-28 — — US claimed
JP-2001507678-A — — 2001-06-12 — — JP claimed
EP-1102590-A1 USE OF A NK-1 RECEPTOR ANTAGONIST FOR TREATING OR PREVENTING ABNORMAL BONE RESORPTION MERCK SHARP & DOHME LTD. (GB) 2001-05-30 — — EP claimed
JP-2001505881-A — — 2001-05-08 — — JP claimed
JP-2001504849-A — — 2001-04-10 — — JP claimed
WO-1998024445-A1 USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING SCHIZOPHRENIC DISORDERS MERCK SHARP & DOHME LIMITED (GB) 1998-06-11 — — WO claimed
WO-1998024442-A1 USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING SEXUAL DYSFUNCTION MERCK SHARP & DOHME LIMITED (GB) 1998-06-11 — — WO claimed
WO-1998024440-A1 USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING STRESS DISORDERS MERCK SHARP & DOHME LIMITED (GB) 1998-06-11 — — WO claimed
WO-1998024446-A1 USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING MOVEMENT DISORDERS MERCK SHARP & DOHME LIMITED (GB) 1998-06-11 — — WO claimed
WO-1997042815-A1 PESTICIDE NOVARTIS AG (CH) 1997-11-20 — — WO claimed
US-5300293-A Mixture of antigrowth agent and dextrin SUMITOMO CHEMICAL CO., LTD. (JP) 1994-04-05 — — US claimed
US-5096710-A Cockroaches, juvenile hormone or chitin synthesis inhibitor, dextrin, plant oil SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1992-03-17 — — US claimed
US-4774090-A UNSATURATED ESTERS, ACTIVATED CHARCOAL, CELLULOSE COATINGS EGYT GYOGYSZERVEGYESZETI GYAR (HU) 1988-09-27 — — US claimed
EP-0203413-A1 Attractive insecticidal bait S.C. JOHNSON & SON, INC. (US) 1986-12-03 — — EP claimed
WO-1983003521-A1 STABILIZED INSECTICIDAL COMPOSITION AND PROCESS FOR THE PREPARATION THEREOF FEKETE, Pál 1983-10-27 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010005511-A1 Insect control by insect growth regulators broadcast by volatilization IGF2BP1, IGFBP2, IGFBP1 ALDH1A1 4482/4885LMNA 4517/4885CYP3A4 4235/4885
US-20010021378-A1 Pesticide DDT, KISS1R, ACHE ALDH1A1 437/4885LMNA 3611/4885CYP3A4 1951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback